TrialCardiovascular diabetology2013

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study.

Arne Ring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.